Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Heng Zhu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5102210249. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis. Co-author DOI 10.1038/s41419-025-08049-2↗
  2. Intratumoral CD38+CD19+B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ebiom.2024.105098↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingcai Meng · 2 shared papers, 2024–2025 · strength 0.43
  2. Chen Liang · 2 shared papers, 2024–2025 · strength 0.43
  3. Xianjun Yu · 2 shared papers, 2024–2025 · strength 0.43
  4. Rong Tang · 1 shared paper, 2025 · strength 0.22
  5. Xiaomeng Liu · 1 shared paper, 2025 · strength 0.22
  6. Zhen Tan · 1 shared paper, 2025 · strength 0.22
  7. Xu He · 1 shared paper, 2025 · strength 0.22
  8. Jianhui Yang · 1 shared paper, 2025 · strength 0.22
  9. Mingming Xiao · 1 shared paper, 2025 · strength 0.22
  10. Zeyin Rong · 1 shared paper, 2025 · strength 0.22
  11. Jin Xu · 1 shared paper, 2025 · strength 0.22
  12. Jie Hua · 1 shared paper, 2024 · strength 0.21
  13. Wei Wang · 1 shared paper, 2024 · strength 0.21
  14. Jin Xu · 1 shared paper, 2024 · strength 0.21
  15. Si Shi · 1 shared paper, 2024 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.